Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
11500mg mesalazine pellets
(D00377)		[1] Mesalazine[1] Mesalamine (D00377) 💬 --[1] 97 💬
2250mg mesalazine pellets
(D00377)		[1] Mesalazine[1] Mesalamine (D00377) 💬 --[1] 97 💬
3500mg mesalazine pellets
(D00377)		[1] Mesalazine[1] Mesalamine (D00377) 💬 --[1] 97 💬
4750mg mesalazine pellets
(D00377)		[1] Mesalazine[1] Mesalamine (D00377) 💬 --[1] 97 💬
5Azathioprine OR Mesalazine
(D00377)		[2] Azathioprine,
Mesalazine		[3] Azathioprine ,
Mesalamine (D00377),
Azathioprine sodium 💬 		--[1] 96 💬
6ClaversalPharmaceutical Form: Gastro-resistant tabletINN or Proposed INN: MesalazineCAS Number: 89-57-6Trade Name: ClaversalPharmaceutical Form: SuppositoryINN or Proposed INN: MesalazineCAS Number: 89-57-6Trade Name: ClaversalPharmaceutical Form: Rectal foamINN or Proposed INN: MesalazineCAS Number: 89-57-6Trade Name: ColitofalkPharmaceutical Form: Gastro-resistant granules for oral suspension in sachetINN or Proposed INN: MesalazineCAS Number: 89-57-6Trade Name: PentasaPharmaceutical Form: TabletINN or Proposed INN: MesalazineCAS Number: 89-57-6Trade Name: PentasaPharmaceutical Form: SuppositoryINN or Proposed INN: MesalazineCAS Number: 89-57-6Trade Name: PentasaPharmaceutical Form: Granules for oral solution in sachetINN or Proposed INN: MesalazineCAS Number: 89-57-6Trade Name: MezavantPharmaceutical Form: Gastro-resistant tabletINN or Proposed INN: MesalazineCAS Number: 89-57-6Trade Name: Mesalazine TevaPharmaceutical Form: Gastro-resistant tabletINN or Proposed INN: MesalazineCAS Number: 89-57-6Trade Name: ColitofalkPharmaceutical Form: SuppositoryINN or Proposed INN: MesalazineCAS Number: 89-57-6Trade Name: ColitofalkPharmaceutical Form: Rectal suspensionINN or Proposed INN: MesalazineCAS Number: 89-57-6Trade Name: SalazopyrinePharmaceutical Form: Gastro-resistant tabletINN or Proposed INN: SulfasalazineCAS Number: 599-79-1Trade Name: PentasaPharmaceutical Form: Rectal suspensionINN or Proposed INN: MesalazineCAS Number: 89-57-6
(D00377)		[1] Mesalazine[1] Mesalamine (D00377) 💬 --[1] 97 💬
7Control group: Mesalazine enema treatment
(D00377)		[1] Mesalazine[1] Mesalamine (D00377) 💬 --[1] 97 💬
8Conventional treatment (glucocoticoid, immunosupressive drugs and/or mesalazine)
(D00377)		[1] Mesalazine[1] Mesalamine (D00377) 💬 --[2] 96, 97 💬
9Delayed and extended release mesalazine
(D00377)		[1] Mesalazine[1] Mesalamine (D00377) 💬 --[1] 97 💬
10Mesalazine
(D00377)		[1] Mesalazine[1] Mesalamine (D00377) 💬 --[3] 46, 96, 97 💬
11Mesalazine (3,600 mg)
(D00377)		[1] Mesalazine[1] Mesalamine (D00377) 💬 --[1] 97 💬
12Mesalazine (Asacol®)
(D00377)		[1] Mesalazine[1] Mesalamine (D00377) 💬 --[1] 97 💬
13Mesalazine (Mesalamine)
(D00377)		[1] Mesalazine[1] Mesalamine (D00377) 💬 --[1] 96 💬
14Mesalazine - TID 1000 mg
(D00377)		[1] Mesalazine[1] Mesalamine (D00377) 💬 --[1] 97 💬
15Mesalazine - TID 2x 500 mg
(D00377)		[1] Mesalazine[1] Mesalamine (D00377) 💬 --[1] 97 💬
16Mesalazine 1000 mg gastro-resistant tablets
(D00377)		[1] Mesalazine[1] Mesalamine (D00377) 💬 --[1] 97 💬
17Mesalazine 250Mg
(D00377)		[1] Mesalazine[1] Mesalamine (D00377) 💬 --[1] 97 💬
18Mesalazine 250Mg Tablet and nitazoxanide 500Mg Oral Tablet
(D00377)		[2] Mesalazine,
Nitazoxanide		[2] Mesalamine (D00377),
Nitazoxanide 💬 		--[1] 97 💬
19Mesalazine 4G Enema
(D00377)		[1] Mesalazine[1] Mesalamine (D00377) 💬 --[1] 97 💬
20Mesalazine 500 mg gastro-resistant tablets (Salofa
(D00377)		[1] Mesalazine[1] Mesalamine (D00377) 💬 --[1] 97 💬
21Mesalazine 500 mg gastro-resistant tablets (Salofalk® 500 mg)
(D00377)		[1] Mesalazine[1] Mesalamine (D00377) 💬 --[1] 97 💬
22Mesalazine EC 500 mg
(D00377)		[1] Mesalazine[1] Mesalamine (D00377) 💬 --[1] 96 💬
23Mesalazine Enema
(D00377)		[1] Mesalazine[1] Mesalamine (D00377) 💬 --[1] 97 💬
24Mesalazine liquid enema
(D00377)		[1] Mesalazine[1] Mesalamine (D00377) 💬 --[1] 97 💬
25Mesalazine slow-release granules
(D00377)		[1] Mesalazine[1] Mesalamine (D00377) 💬 --[1] 97 💬
26Mesalazine Suppository Treatment
(D00377)		[1] Mesalazine[1] Mesalamine (D00377) 💬 --[1] 97 💬
27Mesalazine Sustained-Release Tablets
(D00377)		[1] Mesalazine[1] Mesalamine (D00377) 💬 --[1] 96 💬
28Mesalazine tablets
(D00377)		[1] Mesalazine[1] Mesalamine (D00377) 💬 --[1] 96 💬
29Mesalazine with hydrocortisone sodium succinate
(D00377)		[4] Hydrocortisone,
Hydrocortisone succinate,
Mesalazine,
Succinic acid		[4] Hydrocortisone ,
Mesalamine (D00377),
Hydrocortisone sodium succinate ,
Hydrocortisone succinate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
30Mesalazine, Tripterygium glycosides
(D00377)		[1] Mesalazine[1] Mesalamine (D00377) 💬 --[1] 96 💬
31MMX mesalamine/ mesalazine
(D00377)		[1] Mesalazine[1] Mesalamine (D00377) 💬 --[1] 97 💬
32MMX Mesalamine/Mesalazine
(D00377)		[1] Mesalazine[1] Mesalamine (D00377) 💬 --[1] 97 💬
33MMX Mesalamine/Mesalazine (High Dose)
(D00377)		[1] Mesalazine[1] Mesalamine (D00377) 💬 --[1] 97 💬
34MMX Mesalamine/Mesalazine (Low Dose)
(D00377)		[1] Mesalazine[1] Mesalamine (D00377) 💬 --[1] 97 💬
35Other: Mesalazine
(D00377)		[1] Mesalazine[1] Mesalamine (D00377) 💬 --[1] 97 💬
36Overencapsulated mesalazine tablets
(D00377)		[1] Mesalazine[1] Mesalamine (D00377) 💬 --[1] 97 💬
37SPD476 (mesalazine)
(D00377)		[1] Mesalazine[1] Mesalamine (D00377) 💬 --[1] 97 💬
38SPD476 is a polymeric matrix formulation that displays both delayed- and extended-release of mesalazine
(D00377)		[1] Mesalazine[1] Mesalamine (D00377) 💬 --[1] 97 💬